On April 16, 2018, the FDA will hold a public meeting on “Evaluating Inclusion and Exclusion Criteria in Clinical Trials.” The purpose of the meeting is to bring the stakeholder community together to discuss topics related to eligibility criteria in clinical trials and their impact on patient access to investigational drugs. The meeting will be held at the National Press Club in Washington DC, and there will also be a live webcast for those unable to attend in person.  Register at https://healthpolicy.duke.edu/events/evaluating-inclusion-and-exclusion-criteria-clinical-trials (Federal Register)